MYASTHENIA GRAVIS-LIKE SYNDROME INDUCED BY EXPRESSION OF INTERFERON-GAMMA IN THE NEUROMUSCULAR-JUNCTION

被引:124
作者
GU, DL
WOGENSEN, L
CALCUTT, NA
XIA, CY
ZHU, SM
MERLIE, JP
FOX, HS
LINDSTROM, J
POWELL, HC
SARVETNICK, N
机构
[1] Scripps Res Inst, DEPT NEUROPHARMACOL, LA JOLLA, CA 92037 USA
[2] UNIV CALIF SAN DIEGO, SCH MED, DEPT PATHOL, LA JOLLA, CA 92037 USA
[3] WASHINGTON UNIV, SCH MED, DEPT MOLEC BIOL & PHARMACOL, ST LOUIS, MO 63110 USA
[4] UNIV PENN, SCH MED, DEPT NEUROSCI, PHILADELPHIA, PA 19104 USA
关键词
D O I
10.1084/jem.181.2.547
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Abnormal humoral responses toward motor end plate constituents in muscle induce myasthenia gravis (MG). To study the etiology of this disease, and whether it could be induced by host defense molecules, we examined the consequences of interferon (IFN) gamma production within the neuromuscular junction of transgenic mice. The transgenic mice exhibited gradually increasing muscular weakness, flaccid paralysis, and functional disruption of the neuromuscular junction that was reversed after administration of an inhibitor of acetylcholinesterase, features which are strikingly similar to human MG. Furthermore, histological examination revealed infiltration of mononuclear cells and autoantibody deposition at motor end plates. Immunoprecipitation analysis indicated that a previously unidentified 87-kD target antigen was recognized by sera from transgenic mice and also by sera from the majority of human MG patients studied. These results suggest that expression of IFN-gamma at motor end plates provokes an autoimmune humoral response, similar to human MG, thus linking the expression of this factor with development of this disease.
引用
收藏
页码:547 / 557
页数:11
相关论文
共 45 条
[1]   ATTEMPTS TO IMPLICATE VIRUSES IN MYASTHENIA-GRAVIS [J].
AOKI, T ;
DRACHMAN, DB ;
ASHER, DM ;
GIBBS, CJ ;
BAHMANYAR, S ;
WOLINSKY, JS .
NEUROLOGY, 1985, 35 (02) :185-192
[2]   IDENTIFICATION OF THE 64K AUTOANTIGEN IN INSULIN-DEPENDENT DIABETES AS THE GABA-SYNTHESIZING ENZYME GLUTAMIC-ACID DECARBOXYLASE [J].
BAEKKESKOV, S ;
AANSTOOT, HJ ;
CHRISTGAU, S ;
REETZ, A ;
SOLIMENA, M ;
CASCALHO, M ;
FOLLI, F ;
RICHTEROLESEN, H ;
CAMILLI, PD .
NATURE, 1990, 347 (6289) :151-156
[3]   EXPERIMENTAL MYASTHENIA-GRAVIS - MURINE SYSTEM [J].
BERMAN, PW ;
PATRICK, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (01) :204-223
[4]   FACTORS AFFECTING THE SUSCEPTIBILITY OF DIFFERENT STRAINS OF MICE TO EXPERIMENTAL MYASTHENIA-GRAVIS [J].
BERMAN, PW ;
PATRICK, J ;
HEINEMANN, S ;
KLIER, FG ;
STEINBACH, JH .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1981, 377 (DEC) :237-257
[5]  
BOTTAZZO GF, 1983, LANCET, V2, P1115
[6]   A SENSITIVE ROSETTING ASSAY FOR DETECTION OF ACETYLCHOLINE-RECEPTOR ANTIBODIES USING BC3H-1 CELLS - POSITIVE RESULTS IN ANTIBODY-NEGATIVE MYASTHENIA-GRAVIS [J].
BROOKS, EB ;
PACHNER, AR ;
DRACHMAN, DB ;
KANTOR, FS .
JOURNAL OF NEUROIMMUNOLOGY, 1990, 28 (01) :83-93
[7]   IDENTIFICATION OF A DOMINANT EPITOPE OF GLUTAMIC-ACID DECARBOXYLASE (GAD-65) RECOGNIZED BY AUTOANTIBODIES IN STIFF-MAN SYNDROME [J].
BUTLER, MH ;
SOLIMENA, M ;
DIRKX, R ;
HAYDAY, A ;
DECAMILLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2097-2106
[8]   A NOVEL 87,000-MR PROTEIN ASSOCIATED WITH ACETYLCHOLINE-RECEPTORS IN TORPEDO ELECTRIC ORGAN AND VERTEBRATE SKELETAL-MUSCLE [J].
CARR, C ;
FISCHBACH, GD ;
COHEN, JB .
JOURNAL OF CELL BIOLOGY, 1989, 109 (04) :1753-1764
[10]   HUMORAL PATHOGENESIS OF MYASTHENIA-GRAVIS [J].
DRACHMAN, DB ;
DESILVA, S ;
RAMSAY, D ;
PESTRONK, A .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 :90-105